Itau Unibanco Holding S.A.’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-276
Closed -$30K 386
2023
Q3
$30K Sell
276
-366
-57% -$40.5K ﹤0.01% 334
2023
Q2
$69.3K Buy
+642
New +$72.2K ﹤0.01% 273
2023
Q1
Sell
-59
Closed -$9.03K 517
2022
Q4
$9.03K Buy
+59
New +$9.08K ﹤0.01% 462
2022
Q3
Sell
-16
Closed -$2K 549
2022
Q2
$2K Buy
16
+7
+78% +$1.07K ﹤0.01% 449
2022
Q1
$2K Buy
+9
New +$1.51K ﹤0.01% 455

Other funds holding BNTX

Itau Unibanco Holding S.A.'s BNTX Position: Q4 2023 in Review

Itau Unibanco Holding S.A. sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 276 shares — an estimated $30K sold.

Itau Unibanco Holding S.A. first reported a position in BNTX in Q1 2022 and held it in 5 quarters. The position peaked at $69.3K in Q2 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

  • Itau Unibanco Holding S.A. reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 276 BioNTech shares in Q4 2023, an estimated $30K.
  • Itau Unibanco Holding S.A. first reported a position in BioNTech in Q1 2022 and held it in 5 quarters.
  • Itau Unibanco Holding S.A.'s BioNTech position peaked at $69.3K in Q2 2023.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2023, filed 14 Feb 2024.